Skip to main content
Clinical Trials/IRCT20200607047672N1
IRCT20200607047672N1CompletedPhase 3

Effect of curcumin on cognitive function and inflammatory index in people affected by major depression

Iran University of Medical Sciences0 sites120 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
120

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 65 years (—)
Sex
All

Inclusion Criteria

  • diagnosis of major depression by psychiatrist
  • no history of drug abuse
  • no history of endocrinological disorders
  • no history of immune dysfunction disorders
  • no history of other CNS disorders
  • not being on any type of dieting
  • no suicidal idea
  • no psychosis
  • not using antidepressant medications for last three months
  • not using anti inflammatory medications
  • not using unprescribed medicine
  • speaking Persian fluently
  • ability to write Persian
  • not pregnant

Exclusion Criteria

  • history of drug abuse
  • endocrinological disorders
  • immune dysfunction disorders
  • other CNS disorders
  • using a special form of diet
  • suicide idea
  • using antidepressant medications for last three months
  • using anti inflammatory medications
  • using unprescribed medicine

Investigators

Similar Trials